Expanscience acquires Sublimed

As we are involved in developing new solutions for relieving osteoarthritis-related knee pain, we announce the acquisition of the start-up Sublimed.
Sublimed is a Medtech start-up with which we have been collaborating for several years and which has largely contributed to the development of VitaliTENS, a transcutaneous electrical neurostimulation medical device which acts as a non-drug analgesic alternative.
After 6 years of collaboration, we have therefore decided to come together in order to achieve our common objectives:
This merger allows us both to better control our value chain and to associate ourselves with a company with which we share the same values: choice to manufacture in France, integration of sustainable development issues into the company's strategy, support to the United Nations Global Compact...
top of page